Gyorgy Snell to Animals
This is a "connection" page, showing publications Gyorgy Snell has written about Animals.
Connection Strength
0.086
-
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature. 2021 09; 597(7874):97-102.
Score: 0.028
-
Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021 09 03; 373(6559):1109-1116.
Score: 0.007
-
Broad sarbecovirus neutralization by a human monoclonal antibody. Nature. 2021 09; 597(7874):103-108.
Score: 0.007
-
Tackling COVID-19 with neutralizing monoclonal antibodies. Cell. 2021 06 10; 184(12):3086-3108.
Score: 0.007
-
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021 04 29; 184(9):2332-2347.e16.
Score: 0.007
-
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science. 2020 11 20; 370(6519):950-957.
Score: 0.007
-
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020 07; 583(7815):290-295.
Score: 0.006
-
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability. EMBO Mol Med. 2018 06; 10(6).
Score: 0.006
-
Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile. Bioorg Med Chem. 2018 07 23; 26(12):3261-3286.
Score: 0.006
-
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors. Bioorg Med Chem. 2018 02 01; 26(3):647-660.
Score: 0.005